Food and Medication Administration for ARM210.

The funding award to ARMGO Pharma comes from MDA Venture Philanthropy , part of MDA's translational research program. Related StoriesFlorida Institute finalizes financing contract with Genetic NetworksTesting amniotic liquid could guideline doctors to make delivery planning decisions for preterm birthsDisclosing genetic risk for CHD outcomes in lower low-density lipoprotein cholesterol DMD is one of nine types of muscular dystrophy, a group of genetic, degenerative diseases mainly affecting voluntary muscles.About Actavis Actavis plc , headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a head in a new industry model – Development Pharma. Actavis is targeted on developing, making and commercializing innovative top quality pharmaceuticals, high-quality generic and over-the-counter medications and biologic items for patients all over the world. Actavis markets a portfolio of best-in-class products offering valuable remedies for the central nervous system, eye care, medical aesthetics, gastroenterology, ladies's wellness, urology, anti-infective and cardiovascular therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased usage of affordable, high-quality medicines.